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ABSTRACT
Introduction: Self-management interventions in
patients with chronic conditions have received
increasing attention over the past few years, yet the
meta-analyses encountered considerable
heterogeneity in results. This suggests that the
effectiveness of self-management interventions must
be assessed in the context of which components are
responsible for eliciting the effect and in which
subgroups of patients the intervention works best.
The aim of the present study is to identify condition-
transcending determinants of success of self-
management interventions in two parallel individual
patient data meta-analyses of self-management trials
in patients with congestive heart failure (CHF) and in
patients with chronic obstructive pulmonary disease
(COPD).
Methods and analysis: Investigators of 53
randomised trials (32 in CHF and 21 in COPD) will be
requested to share their de-identified individual
patient data. Data will be analysed using random
effects models, taking clustering within studies into
account. Effect modification by age, sex, disease
severity, symptom status, comorbid conditions and
level of education will be assessed. Sensitivity
analyses will be conducted to assess the robustness
of the findings.
Ethics and dissemination: The de-identified
individual patient data are used only for the purpose
for which they were originally collected and for
which ethical approval has been obtained by the
original investigators. Knowledge on the effective
ingredients of self-management programmes and
identification of subgroups of patients in which
those interventions are most effective will guide
the development of evidence-based personalised
self-management interventions for patients with
CHF and COPD as well as with other chronic
diseases.
Trial registration number: PROSPERO:
CRD42013004698.
INTRODUCTION
With the rising number of people suffering
from one or more chronic conditions,1 2
interventions to support self-management
have received increasing attention over the
past few years. Such interventions aim to
teach patients the skills to actively participate
in the management of their chronic condi-
tion and generally comprise skills for
symptom monitoring, management of medi-
cation use and changing health behaviours.3
The evidence presented so far in
meta-analyses seems to favour self-
management interventions for improving a
range of outcomes in various patient
groups.4–10 Yet several authors encountered
considerable heterogeneity in the outcomes
analysed,4 9 sometimes leading to contradict-
ory findings.11 12 A recently published large
randomised controlled trial (RCT) among
patients with chronic obstructive pulmonary
disease (COPD) even reported unexplained
higher mortality rates among the patients in
Strengths and limitations of this study
▪ This individual patient data (IPD) meta-analysis
will evaluate the effects of self-management
interventions across two chronic conditions:
patients with chronic heart failure and patients
with chronic obstructive pulmonary disease.
▪ Embedding of the study in an international
network and careful consideration of methodo-
logical challenges of the IPD approach have
resulted in a robust design of data collection and
analysis.
▪ Retrieval bias might occur if not all the original
investigators are willing or able to participate and
not all individual patient data can be included.
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the intervention group, who received one group session
and multiple individual sessions addressing problem-
solving techniques and lifestyle changes, followed up by
telephone contacts.13
One explanation for those ambiguous findings might
be the high variation across studies evaluating self-
management interventions. Self-management interven-
tions can be regarded as complex interventions.14 The
intervention studies differ not only in procedural aspects
such as content, duration and intensity,14 but also in the
patient populations included and outcomes measured.15
The question whether self-management interventions
are effective cannot be answered without considering
which components are responsible for eliciting the
effect and identifying in which subgroups of patients the
intervention is most effective. Few attempts have been
made to identify determinants of success across condi-
tions,15 which is rather surprising since a majority of the
patients with a chronic condition suffer from comorbid-
ity.16 17 Individual trials in different chronic conditions
have reported large proportions of non-complying and
non-responding patients.3 Based on these results, the
question arises if barriers to adhere to interventions and
adopt self-management behaviour are disease-specific or
transcend specific conditions.
The combination of studies in a meta-analysis or
meta-regression might provide insight into which
programme-specific components are likely to be effect-
ive. Intervention studies, however, may differ not only
with regard to the intervention evaluated, but also with
regard to characteristics of the population included.
Comparisons of patient characteristics across studies
based on aggregate data in a ‘classical’ meta-analysis may
be subjective to ecological bias.18 A meta-analysis of indi-
vidual patient data (IPD) overcomes this potential draw-
back and enables a straightforward analysis of both
subgroups of patients in whom the intervention will be
most effective and the effects of relevant components of
the studied (complex) interventions.19 Sufficient power
for analysing subgroups is warranted due to the larger
numbers of patients included in the analyses, which
overcomes the problems with limited power of subgroup
analyses experienced in individual trials.19 20 An IPD
meta-analysis therefore seems an attractive approach for
unravelling the determinants of success of self-
management interventions.
In order to discover the determinants of success of
self-management interventions for chronic disease ‘at
large’ (ie, condition-transcending), the present study
will initiate two parallel IPD meta-analyses of self-
management trials in two different chronic conditions:
in patients with chronic heart failure (CHF) and in
patients with COPD. The focus will be on patients with
CHF or COPD because of the large number of patients
confronted with either one or both of these condi-
tions2 21 and the large number of available self-
management trials. Although the management of these
conditions differs considerably, both patient groups are
confronted with daily adherence to a drug treatment
and lifestyle advice and monitoring of signs and symp-
toms is important for the prevention or timely detection
of exacerbations.21 22 This makes self-management an
inevitable part of care for those patient groups.21 23 In
both conditions, self-management interventions are
extensively studied, but the outcomes of published
studies are heterogeneous.6 11
Objectives
The present paper provides a detailed description of the
rationale and design for this IPD meta-analysis. The
primary objective is to identify programme-specific and
patient-specific determinants of the effect of self-
management interventions on health-related quality of
life (HRQoL), mortality, all-cause and disease-related
hospital admissions and days in hospital in patients with
CHF and patients with COPD.
In addition to two independent analyses for self-
management trials in patients with CHF and patients
with COPD, we will compare the results in both patient
groups and investigate the similarities and differences in
determinants. The secondary objective is to identify
programme-specific and patient-specific determinants of
successful self-management interventions in chronic
disease ‘at large’, that is, condition-transcendent
determinants.
METHODS AND ANALYSIS
Identification of studies
An extensive literature search has been conducted in
the electronic databases of PubMed, EMBASE and
Cochrane Central Register on Controlled Trials,
PsycINFO and CINAHL from January 1985 to June
2013. Medical Subject Heading (MeSH) terms and key
words used in the title and abstract were ‘chronic heart
failure’, ‘chronic obstructive pulmonary disease’, ‘self-
management’, ‘self-care’, ‘patient-education’, ‘rando-
mised controlled trial’ and synonyms (see online
supplementary appendix 1 for PubMed search strategy
as an example of the complete search terms). Reference
lists of relevant systematic reviews were hand-searched
and experts in the domain were consulted to ensure a
complete coverage of relevant studies.
Included studies
Studies included in this IPD meta-analysis are RCTs with
concealed allocation to treatment. Inclusion criteria for
patients are an established primary diagnosis of CHF or
COPD according to the prevailing international clinical
guidelines.21 23 This IPD meta-analysis aims to deter-
mine patient-specific effect modifiers; therefore, no
exclusion criteria apply with regard to, for example,
disease severity or comorbidities.
Since a gold standard of which essential elements con-
stitute a self-management intervention is lacking,24 an
extensive literature search was performed before an
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international group of seven experts reached consensus
during a conference meeting on essential components
for defining ‘self-management intervention’. This
resulted in inclusion criteria for interventions, with
included interventions requiring a minimum of two of
the following components: (1) active stimulation of
symptom monitoring, (2) education in problem solving
skills (ie, self-treatment such as managing acute exacer-
bations, resource utilisation and stress/symptom man-
agement) and enhancement of (3) medication
adherence, (4) physical activity, (5) dietary intake or (6)
smoking cessation. The intervention selection is sche-
matically presented in figure 1.
Studies are included in the IPD meta-analysis if they
(1) studied an intervention which fulfilled the require-
ments of the definition of self-management interven-
tion, (2) compared the self-management intervention to
usual care or another self-management intervention, (3)
reported data on one or more of the relevant outcomes
for this IPD meta-analysis (see below), (4) followed
patients for at least 6 months and (5) were reported in
English, Dutch, French, German, Italian, Portuguese or
Spanish.
Methodological quality
Quality appraisal is performed by two independent
researchers not involved in any of the primary studies.
The methodological quality of the studies is assessed
through three relevant criteria based on the ‘Risk of
bias’ tool from the Cochrane Collaboration25:
1. Random concealed allocation to treatment;
2. Intention-to-treat analysis;
3. Other deviances (eg, discrepancies in baseline
characteristics, high drop-out rates with unbalances
between groups and risk of contamination).
Discrepancies between the two researchers are solved
through discussion with a third researcher. Results of
the quality appraisal will be applied in sensitivity analyses
including only studies with a low risk of bias to assess the
impact of studies of lower methodological quality.
Data collection
Fifty-three RCTs (32 in CHF patients, 21 in patients with
COPD) have been selected for this IPD meta-analysis
(see online supplementary appendix 2 for a list of
included studies). The original investigators are
requested to participate in this IPD meta-analysis
through an invitation by email, written in English,
Spanish, Portuguese or Dutch. Email addresses have
been obtained through contact details of recent publica-
tions or retrieval of affiliations. A reminder is sent after
several weeks if no response is received, after which
other investigators of the original trial will be
approached. Investigators will be asked to send their
encrypted data, preferably electronically, only after
written agreement, by creating encrypted files (in a
WinZip file). Standardised data collection forms with
the minimum required data items are provided to inves-
tigators, but they can send their data in any format most
convenient for them (eg, SAS, SPSS and Microsoft Excel
spreadsheet). Additionally, investigators are asked to
check the extracted intervention characteristics from
their studies to ensure a correct interpretation of
interventions.
The data items to be collected are based on clinical
relevance, previously reported meta-analyses
(programme-specific determinants) and subgroup ana-
lyses in RCTs (patient-specific determinants). Table 1
presents the data items investigators are requested to
share.
Figure 1 Inclusion criteria for
interventions.
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Data will be saved in the original format as sent by the
investigator and subsequently will be converted to a
common SPSS format (IBM Corp. Released 2011. IBM
SPSS Statistics for Windows, V.20.0 Armonyk, New York:
IBM Corp) for data checking and recoding. Data of
each trial will be checked with regard to the range of
variables measured, extreme values, internal consistency,
missing values and consistency with published reports.
The details of the interventions as presented in table 2
are cross-checked with trial protocols and published
reports. Discrepancies with published results, missing
data or inconsistencies will be verified with the original
investigators and any problems resolved by consensus.
Across studies, variables might be coded differently
and recoding may be necessary to create uniform cat-
egories in the combined dataset. To ensure the correct
interpretation of original categories and a correct recod-
ing, new categories are only coded after consultation of
the original investigators. All datasets from individual
trials will be assigned a unique trial ID before being
merged into the central database.
Project management
One of the major challenges in IPD meta-analyses is
good communication across cultural and language bar-
riers and careful management of and negotiation with
collaborating investigators.20 For this IPD meta-analysis,
an international collaborative study group is established,
the Tailoring of Self-managemenT and E-health
Individual Patient Data (TASTE-IPD) study group. From
each original trial, one representative becomes a
member of the collaboration. Representatives of the
trials will be invited to teleconferences (at least twice a
year) and meetings scheduled during international
Table 1 Data items investigators are requested to share
Study level
Methodology
Study level
Intervention
Patient level
Characteristics
at baseline
Patient level
Intervention as
implemented
Patient level
Outcomes
▸ Year of
recruitment
▸ Location of
recruitment
▸ Method of
randomisation
▸ Blinding to
group
assignment
▸ Mode(s) of
delivery
▸ Content covered
in intervention
▸ Number of
planned contacts
during intervention
▸ Duration of the
intervention
▸ Type of training
given to
interventionists
▸ Sex
▸ Age
▸ Years since diagnosis
▸ Disease severity
(CHF=LVEF;
COPD=FEV1%, FEV1,
FVC)
▸ Symptom status
(CHF=NYHA class;
COPD=dyspnoea)
▸ Comorbid conditions
▸ Level of education
▸ Ethnic minority
▸ Living alone
▸ Self-efficacy
▸ Depression
▸ Body mass index
▸ Smoking status
▸ Number of actual
contacts with patient
during intervention
▸ Content covered with
individual patient
▸ Targeted behaviour
achieved
▸ Loss-to-follow-up and
reason
▸ Health-related quality of
life (score on
instrument)
▸ Mortality (yes/no;
time-to-event)
▸ All-cause hospital
admissions (number;
time-to-first-event)
▸ Disease-related hospital
admissions (number;
time-to-first-event)
▸ All-cause days in
hospital (total number of
days)
▸ Disease-related days in
hospital (total number of
days)
CHF, chronic/congestive heart failure; COPD, chronic obstructive pulmonary disease; FEV1. forced expiratory volume in 1 s; FEV1%,
predicted forced expiratory volume in 1 s; FVC, forced vital capacity; LVEF, left ventricular ejection fraction; NYHA, New York Heart
Association.
Table 2 Determinants to be analysed
Determinants
Programme-specific ▸ Number of planned contacts
▸ Duration of the intervention
▸ Training given to interventionists
(standardised/heterogeneous)*
▸ Group contact with peers (y/n)*†
▸ Keeping diaries for
symptom-monitoring (y/n)‡
▸ Goal-setting skills (y/n)*†
▸ Problem-solving skills (y/n)*†
▸ Support allocation skills (y/n)*
Patient-specific ▸ Sex
▸ Age
▸ Disease severity
▸ Symptom severity
▸ Number of comorbid conditions
▸ Depression
▸ Level of education
Optional variables (only analysed if
sufficient data available):
▸ Recently diagnosed
▸ Self-efficacy
▸ Living status
▸ Body mass index
▸ Smoking status
*Based on self-management literature.
†Based on social cognitive theory.
‡Based on behavioural techniques.
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conferences (annually). Separate teleconferences/meet-
ings will be held for the COPD and CHF trials. During
those meetings, major methodological decisions and
(preliminary) results will be discussed. Between meet-
ings, members of the study group are updated on study
progress through newsletters. Before submission of a
manuscript for publication, a draft version will be circu-
lated among investigators to allow for comments, revi-
sion and approval. Publications are authored with the
names of the investigators where possible and on behalf
of the collaboration as a whole with names of other par-
ticipating investigators listed in the acknowledgements.
During the project, the collaboration might decide on
new research questions which can be answered through
a re-analysis of the combined database.
The project management team will be responsible for
management decisions within the collaboration and will
organise communication with investigators through mail-
ings, teleconferences and meetings. Its members carry
the responsibility for the decisions with regard to daily
management of the study, collection of the individual
data, development of the core dataset and statistical ana-
lysis. The project management team is supported by
expert members, who are self-management experts in
the fields of either CHF or COPD.
Outcome measures
The present study will focus on various outcome mea-
sures. These include:
1. Change in HRQoL at 6 and at 12 months. A distinc-
tion is made between disease-specific and generic
HRQoL to address the different assessment of
HRQoL applied in the original studies;
2. Mortality (time-to-event, % death at 6 and at
12 months);
3. Hospitalised for any cause (time-to-event, % hospita-
lised at 6 and at 12 months);
4. Total number of days spent in hospital for any cause
at 6 and at 12 months;
5. Hospitalised for resp. CHF or COPD (time-to-event,
% hospitalised at 6 and at 12 months);
6. Total number of days spent in hospital for resp. CHF
or COPD at 6 and at 12 months.
Statistical analyses
First, statistical analyses will be performed for CHF and
COPD studies separately to meet the primary objective,
but the analyses will be similar. To address the secondary
objective, analyses will be repeated combining the data
from both patient groups to assess whether effect deter-
minants transcend the specific chronic condition. An
additional covariate will be included in the models
below to indicate the specific condition. All analyses will
be performed in R for Windows V.2.15.3 (R
Development Core Team, Released 2013, Vienna,
Austria: R Foundation for Statistical Computing), accord-
ing to the intention-to-treat principle. Missing data in
studies will be addressed by using multiple imputations
by chained equations.26 Missing values will only be
imputed within studies.
The IPD will be analysed using a one-stage approach,
that is, simultaneously analysing all observations while
accounting for clustering of observations within
studies.27 For time-to-event data, the effects of self-
management will be quantified by estimating HR and
95% CI. Cox proportional-hazard models will be used to
analyse the data, including a cluster statement to allow
inter study variability. For binary outcome data (mortal-
ity, all-cause and disease-related hospital admissions),
risk ratios and 95% CI will be estimated using log-
binomial mixed-effects models. Effects on continuous
outcomes (HRQoL and days in hospital) will be quanti-
fied by mean differences and 95% CI and will be esti-
mated using linear mixed effects models. In the
log-binomial and linear mixed-effects models, random
intercepts and random slopes will be included to take
clustering within studies into account. Heterogeneity is
assessed with the I2 statistic.28
Programme-specific determinants
To identify programme-specific determinants of self-
management interventions, the aforementioned models
are complemented with covariates for programme
characteristics. Table 2 presents an overview of the poten-
tial programme-specific determinants to be studied. The
programme-specific determinants are based on social
cognitive theory,29 self-management literature24 30 31 and
successful behavioural techniques.32 Additionally, the
intensity and duration of interventions will be studied,
since these have shown to be related to outcomes in
behavioural interventions.33 Programme-specific determi-
nants are considered significant if the p value is <0.05.
Patient-specific determinants
The aforementioned models will be extended to study
effect modification by patient characteristics. Effect
modification implies that the effect of the intervention
on an outcome differs depending on the value of a
third variable, the effect modifier. This can be studied
by including the interaction terms in the models. An
overview of potential effect modifiers is presented in
table 2. This is a selection of clinically relevant variables,
which can be expected to have been collected across the
majority of trials in a comparable manner. Next to age,
sex, disease severity and symptom status, the present
study will focus on comorbid conditions (with specific
attention to depression) and level of education, as those
variables have been shown to be related to change in
self-management behaviour in chronic patients.34 35
Since the amount of effect modifiers included in the
models is restricted by the total number of patients
included for analysis, the optional patient-specific effect
modifiers will only be included if sufficient patient data
are available.
To assess whether the effect of self-management is
modified by prespecified patient characteristics, each
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model will include interaction terms of the patient
characteristics in table 2. Hence, the independent vari-
ables in each model are the random intercepts and
slopes for the individual studies, the self-management
intervention, the specific patient characteristic and inter-
action terms (self-management by patient character-
istics), with the outcome as a dependent variable.
Coefficients of interaction terms will be presented with
95% CI.
Sensitivity analysis
Sensitivity analysis will be performed to assess the robust-
ness of the findings. Inclusion of aggregate data of
studies for which IPD are unavailable will be performed
to test whether IPD are representative of all eligible
studies. A complete-case analysis will be carried out to
assess the effects of imputing missing data. In addition,
inclusion of only studies with a low risk of bias will be
performed to assess the impact of studies of lower meth-
odological quality on the findings. Adaptations to the
statistical analysis plan will be made only after the study
group has been consulted and consensus has been
reached.
ETHICS AND DISSEMINATION
The de-identified IPD are used only for the purpose for
which they were originally collected and for which
ethical approval has been obtained from the individual
studies. In the case of re-analysis of de-identified patient
data, informed consent is not deemed necessary. Data
will be included in the IPD meta-analysis only after
written agreement of the original investigator and after
de-identification. Data will remain the property of the
original investigators at all times, and they have the right
to withdraw their data from the study. The shared data-
sets will not be used for purposes other than declared in
the protocol without the permission of the original
investigators. Data are considered confidential and will
be stored on a secured location on the digital network
of the UMC Utrecht that can only be accessed by the
members of the project management team.
This project is embedded in the research line TASTE,
which aims to enhance the effectiveness of self-
management for chronic conditions.36 Consolidation of
generating high-quality scientific output is strengthened
by collaboration with international universities, educa-
tional institutes and patient/provider organisations.
Results of this IPD meta-analysis will be disseminated in
international peer-reviewed journals and at international
conferences.
DISCUSSION
To the best of our knowledge, the present study will be
the first IPD meta-analysis on comprehensive self-
management interventions to be conducted across two
chronic conditions: CHF and COPD. We aim to identify
in each patient group which programme-specific and
patient-specific determinants modify the effects of self-
management interventions on HRQoL, mortality and
healthcare use. Our secondary aim is to identify which
determinants transcend both conditions and are asso-
ciated with better outcomes of self-management interven-
tions in chronic disease ‘at large’. This is crucial
information in view of the common approaches in self-
management strategies across conditions and the rising
number of patients with multiple chronic conditions.16 17
A re-analysis of self-management trials on the level of
individual patients is essential to study programme and
patient characteristics as possible determinants of
success.18 IPD meta-analyses are still quite rare in the
field of complex interventions,37–39 even though the lit-
erature on the methodology of IPD meta-analyses is
increasing.27 Substantial efforts have been made to care-
fully design the present IPD meta-analysis and anticipate
the limitations of the IPD approach. Based on the
lessons learnt from other IPD meta-analyses in this area,
the important methodological considerations are met as
shown in table 3.37–39 With our extensive search strategy,
we have minimised the chance of missing relevant trials.
Since self-management interventions are complex inter-
ventions, a clear definition of inclusion and exclusion
criteria is essential for a transparent selection of studies
included. We carefully discussed and documented the
reasons underlying our choice of the required data
items, statistical plan and preplanned sensitivity analyses
to ensure that we collect the necessary information to
assess the robustness of findings and minimise bias.
Despite our careful methodological considerations,
some of our methodological choices can be discussed.
First, the choice of inclusion date. The earliest study
included in our selection dates back to 1995, resulting
in a time span of nearly 20 years over which individual
trials were conducted. To ensure completeness, we have
chosen not to exclude the first self-management trials,
although the ‘usual care’ provided to control groups in
these studies will not be comparable to the usual care
that is more recent. Second, for our primary analysis, we
have chosen to impute missing data only within studies.
With this approach, we will limit our analysis to the
studies which have provided data on the selected effect
modifiers, which might introduce bias if data are not
missing completely at random. Another solution might
be to impute missing data across studies. Yet, the multi-
level methods required to achieve this are quite novel
and multiple imputation is generally recommended for
imputing sporadic missing values instead of systematic-
ally missing data.40 As non-collected data will be system-
atically missing in that specific study, we have chosen the
conventional approach of multiple imputation within
studies only. Third, the quality of our findings is highly
dependent on the quality of the original design, the
quality and completeness of the data and the level of
detail provided by the original researchers.25 Retrieval
bias may occur if not all the original investigators are
willing or able to participate and we cannot obtain all
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IPD. Therefore, sensitivity analyses are planned to assess
the impact on our findings.
With this planned IPD meta-analysis, we aim to
advance our understanding of effectiveness of self-
management interventions. Knowledge on the effective
ingredients of programmes contributes to the develop-
ment of evidence-based personalised self-management
interventions. By identifying subgroups of patients in
which self-management interventions are most effective,
we will be better able to tailor future interventions and
personalise care for patients with chronic disease.
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